Skip to main content

Brian J. Platton


[email protected]



Brian’s practice focuses on transactions in health care and life sciences, and the regulatory triage related to such transactions. He represents managed care companies, academic medical centers and medical schools, non-academic hospitals, non-hospital providers, contract manufacturing organizations, investors in health care and life sciences, including venture capital funds, private equity funds and hedge funds, life sciences companies, and health care information technology companies. For nearly 40 years, Brian has advised clients with respect to mergers, acquisitions and divestitures, financings, investments, licensing, joint ventures, innovation programs, strategic alliances and partnerships, governance structures, marketing arrangements, services arrangements, outsourcing, and other contracting.

Brian has presented on panels on behalf of organizations as the Practising Law Institute, the American Bar Association, and the New York State Bar Association.

During law school, he served as executive editor of the Journal of International and Comparative Law.


  • New York Law School (JD)
  • State University of New York (BA)


  • Represented a large and prestigious academic medical system in multiple joint ventures, including one for the research and development of certain cancer therapies; and another with two parties: a software company that has a clinical discovery platform, and a university health science center.
  • Represented a prestigious academic medical system in multiple joint venture affiliations with regional hospitals outside of New York City, relating to the medical school’s nationally recognized expertise in assisted reproductive services, including in vitro fertilization. We also represented certain related fertility physicians in connection with a spinoff of their practice to an independent entity managed by a private equity backed fertility services company.
  • Regularly counsels a large health plan offering Medicare Advantage, Medicaid Managed Care, Commercial, and Managed Long Term Care products on various matters necessary to the growth of the health plan, including mergers and acquisitions, financings, Medicare audits and reporting, ACA benefits and compliance, investigations and executive compensation matters.
  • Acted as transaction counsel for a New York-based non-profit organization established in the 19th century that has been providing a broad range of services to the elderly. Our representation related to a strategic partnership and related transactions with a New York-based non-profit organization that is one of the largest and most innovative health systems in the region. We provided all of the necessary services, including advising the Board of Trustees; drafting and negotiating all necessary documentation; conducting due diligence, and providing health regulatory and antitrust advice and counsel, including assisting with the requisite Hart-Scott-Rodino Antitrust Improvements Act (HSR) filing.
  • Represented a community-based not-for-profit managed care organization in connection with the transfer of its membership interest in a plan serving over 300,000 enrollees to another not-for-profit health insurer serving more than 613,000 enrollees in the states of New York, Vermont, and New Hampshire.
  • Represented one of the largest and most prestigious health systems in New York City in its sale of its outreach laboratory business to a leading, international life sciences company. Our representation included all aspects of the transaction, including drafting and negotiating all necessary documents, providing structuring and health regulatory advice and counsel, and antitrust advice and counsel, including assistance with the HSR filing.
  • Represented a leading academic health system with respect to the creation and operation of a contract manufacturing organization (CMO).
  • Represented a commercial CMO with respect to various cell therapy clinical and commercial manufacturing agreements, including with large pharmaceutical and biotechnology companies.

  • Represented a large academic health system and affiliated medical school in connection with an investment in, and beta test agreement with a data analytics company.

  • Represented a non-profit managed care organization in connection with the sale of an affiliate operating in an adjacent state, and the withdrawal from market, runout of liabilities, wind down and dissolution of such affiliate.

  • Represented a large academic health system with respect to its participation in a data aggregation and commercialization joint venture, and its innovation programs.

  • Represented a large hedge fund in connection with an alternative financing of and possible investment in a non-profit managed care plan.

Recognition & Awards

  • Chambers USA: New York – Healthcare (2011 – 2021)
  • Nightingale's Healthcare News: Outstanding Healthcare Transaction Lawyer (2007)
  • Best Lawyers in America: Health Care Law (2016 – 2021)
  • Included on the New York Super Lawyers: Health Care list (2018-2020)


  • Member, American Health Lawyers Association
  • Member, New York State Bar Association
  • Member, Health Law Committee, New York City Bar Association
  • Member, American Bar Association


Viewpoint Thumbnail

The Evolution of Private Equity Investment in Health Care

December 5, 2018 | Video | By Brian J. Platton

Brian Platton discusses the changing landscape of private equity investment in health care, specifically the rise of investments in management entities in Corporate Practice of Medicine states as well as joint ventures and other creative ways to partner with tax-exempt entities. 
Read more
As discussed in a previous post, CMS recently issued a proposed rule implementing the Sunshine Act, but many pharmaceutical and medical device manufacturers are still trying to determine the scope of their continuing obligations under related state laws, such as the Massachusetts “gift ban” law. 
Read more

News & Press

Press Release Thumbnail
Mintz partner and Massachusetts lawyer Julie Korostoff is one of 49 attorneys recognized as “Leaders in Their Fields” by the 2018 Chambers USA: America's Leading Lawyers for Business guide. Chambers named Korostoff a “Recognized Practitioner” in Technology.
Press Release Thumbnail
Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named “Lawyer of the Year” in their respective practice areas.
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas. 
Brian Platton, a Member in Mintz’s New York office, is quoted in this Ambulatory M&A Advisor article discussing what sellers can expect when working with private equity, and what private equity’s expectations are for the sellers.
The 2015 Chambers USA: America's Leading Lawyers for Business guide names 52 Mintz, Cohn, Ferris, Glovsky and Popeo, P.C.  attorneys as “Leaders in Their Fields.”



Healthcare Law & Compliance Institute

International Performance Management Institute

Virtual Event

Conference Reference Image

Introduction to Health Law

Lawline Webinar